BMP9-Smad1/5/9 Signalling Mediates Osteogenic Differentiation and Alveolar Bone Remodelling in hPDLFs Authors: Jing Hu, Ni An, Sheng Chang, Song Zhao, Rongjian Su, Jin Huang Published: 2026 ABSTRACT ObjectivesThis study aimed to investigate the role of BMP9-Smad1/5/9 in the osteogenic differentiation and alveolar bone remodelling of Human periodontal ligament fibroblasts (hPDLFs) under the action of cyclic tensile stress (CTS).MethodsAn orthodontic tooth movement (OTM) model was established in Sprague-Dawley (SD) rats, the expression status of OCN and BMP9 was measured using immunohistochemistry. hPDLFs were subjected to CTS treatment (10% elongation, 0.5 Hz) to simulate the mechanical microenvironment during orthodontic treatment. The activity of ALP was detected by colorimetric assay and azo coupling staining, respectively. Mineralized nodules were visualized by Alizarin red staining. The expression levels of osteogenesis-related genes including RUNX2, ALP, and OCN were evaluated. To determine the role of BMP9-Smad1/5/9 in CTS-induced osteogenic differentiation, BMP9-Smad1/5/9 signalling was diminished by small RNA against BMP9 and the inhibitor of Smad signalling, the potential of osteogenic differentiation was assessed.ResultsBMP9 expression was upregulated in the tension-side periodontal ligament tissues of SD rats, as well as in hPDLFs stimulated by CTS. hPDLFs exhibited increased osteogenic differentiation potential under CTS induction, as evidenced by increased ALP activity, upregulated expression of osteogenesis-related genes, increased mineralized nodule formation and ALP staining. Mechanistically, CTS elevated the phosphorylation levels of Smad1/5/9. Silencing BMP9 attenuated CTS-induced osteogenic differentiation and reduced Smad1/5/9 phosphorylation. Moreover, inhibition of BMP9-Smad1/5/9 signalling pathway suppressed the osteogenic potential of hPDLFs.ConclusionsCTS increased the osteogenic potential of hPDLFs. Silencing of BMP9 and inhibition of the BMP9-Smad1/5/9 signalling inhibited the osteogenic differentiation of hPDLFs induced by CTS.Clinical RelevanceThese findings provide mechanistic insights into periodontal tissue remodelling and may contribute to the development of strategies to accelerate orthodontic tooth movement in clinical practice. Introduction Orthodontic treatment is widely recognized as a reliable strategy to correct malocclusion, which facilitates the 3-dimensional movement of teeth by the application of precise orthodontic forces.1, 2, 3 Bone remodelling profoundly influences the outcome of orthodontic therapy. Accelerating bone remodelling is expected to curtail treatment course, thereby improving the efficiency of orthodontic therapy. The periodontal ligament (PDL), as a direct sensor and effector of mechanical force, plays a vital role in sustaining periodontal tissue homeostasis and creates a microenvironment conducive to bone remodelling in response to mechanical stimuli.4, 5, 6 Human periodontal ligament fibroblasts (hPDLFs) are the predominant cellular component of the PDL, serving as vital mechanoreceptors and core effector for mechanical force transduction.7,8 These cells possess the capacity for osteogenic differentiation and participate in various physiological processes, including alveolar bone repair, regeneration, and remodeling.9, 10, 11 Several lines of evidence have shown that the osteogenic differentiation of hPDLFs can be activated and modulated by various extracellular stimuli. For example, concentrated growth factor and leukocyte-and platelet-rich fibrin facilitate the proliferation and osteogenic differentiation of periodontal ligament fibroblasts (PDLFs).12 Similarly, Calcitonin promotes collagen synthesis and osteogenic differentiation of hPDLFs via the TGF-β1 and BMPs signalling pathways.13 Recent advances also show that silver nanoparticles promote osteogenic differentiation of hPDLFs by regulating the RhoA–TAZ axis.14 Mechanical stress is a key driver of alveolar bone remodelling during orthodontic treatment.15 In the early phase of OTM, hPDLFs act as key mediators and display temporally regulated, differentiated expression patterns of cytokines and related mediators.16 Simulated orthodontic compressive strain and physiological concentrations of 25(OH)D3 can regulate the expression of orthodontic tooth movement-related genes in hPDLFs.17 Mechanical tensile strain induces ephrin-B2 upregulation in hPDLFs through the FAK-Ras-ERK1/2-SP1 cascade, which promotes osteogenic gene expression and osteogenic differentiation.18 Thus, it is urgent to investigate the signal transduction events triggered by mechanical stress in hPDLFs will contribute to elucidating the molecular mechanisms governing periodontal tissue remodelling under orthodontic force. Bone morphogenetic proteins (BMPs) belong to the transforming growth factor-beta superfamily and play a crucial role in embryogenesis, haematopoiesis, neurogenesis, bone formation, and stem cell differentiation.19, 20, 21 Over 20 BMP isoforms have been identified, among which BMP2, BMP6, BMP7 and BMP9 are well recognized as critical regulators of osteogenic differentiation in mesenchymal stem cells (MSCs).22,23 BMP9 (also termed GDF-2), initially discovered in embryonic mouse liver, exhibits stronger osteogenic induction in MSCs, osteogenic progenitor cells and osteoblasts than other BMPs.24, 25, 26 CTS can upregulate the expression of BMP2, facilitating the osteogenic differentiation of Human Periodontal ligament stem cells (hPDLSCs).27 Notably, BMP9 possesses greater osteogenic potency than BMP2 and is resistant to the inhibitory effect of noggin in MSCs.28 In addition, CTS has been proven to induce mineral deposition in human periodontal ligament cells, accompanied by elevated BMP9 expression.29 Although the osteogenic and bone-forming roles of BMP9 have been extensively validated, the underlying mechanism by which periodontal ligament fibroblasts mediate alveolar bone remodelling during orthodontic tooth movement remains largely unclear. This study investigated the effect of CTS on the osteogenic differentiation and explored the role of BMP9/Smad1/5/9 signalling in CTS induced osteogenic differentiation. Our data showed that CTS induced the osteogenic differentiation of hPDLFs. BMP9/Smad1/5/9 signalling was crucial for this process. Together, our findings may provide a novel strategy to increase the efficiency of orthodontic therapy. Materials and methods Cell culture and identification Healthy premolars or third molars were obtained from orthodontic patients aged 18 to 25 years at the Department of Stomatology, The First Affiliated Hospital of Jinzhou Medical University. The periodontal ligament was isolated from the extracted teeth, and primary human periodontal ligament fibroblasts were harvested using the tissue block method. Cell were cultured in a humidified atmosphere containing 5% CO2 at 37°C. The culture medium consisted of α-minimum essential medium (α-MEM) (Gibco) supplemented with 10% foetal bovine serum (FBS) (Procell), 100 U/mL penicillin (Procell), and 100 μg/mL streptomycin (Procell). hPDLFs at passages 3-4 were used for subsequent experiments, and a cell growth curve was established. The expression levels of cytokeratin10 (CK10) (bs-2700R, Bioss, rabbit, 1:100), vimentin (10366-1-AP, Proteintech Group, rabbit, 1:400), and fibroblast-specific protein 1 (FSP1) (bs-3759R, Bioss, rabbit, 1:200) were examined by immunofluorescence assay. Cyclic tensile stress (CTS) application Cyclic tensile stress was applied to hPDLFs with a Flexcell Strain Unit Fx-5000 (Flexcell Corp), Cells were seeded onto 6-well BioFlex collagen I-coated plates (Flexcell Corp) until they reached confluence. Cells were subjected to cyclic tensile stress (10% elongation, 0.5 Hz, 60 cycles/min) in medium α-MEM containing 5% FBS for up to 6,12,24 hours. Static control cells were subjected to the same conditions, except cyclic tensile stress was not applied. Immunofluorescence For the immunofluorescence staining procedure, tissue sections were incubated with primary antibody against p-Smad1/5/9 (13820T, Cell Signalling Technology, rabbit, 1:400) overnight at 4°C. Following 3 washes with PBST buffer, the slides were labeled with an Alexa Fluor 488(AF488)-conjugated anti-rabbit antibody (Cell Signalling Technology) at room temperature for 1 hour. Cell nuclei were counterstained using DAPI (Beyotime). Images were captured using a confocal microscope (Leica SP5 II). Quantitative real‑time PCR (qRT‑PCR) Total RNA was extracted from hPDLFs using a commercial RNA extraction kit. The RNA concentration was determined by measuring absorbance at 260/280 nm. Reverse transcription was conducted using the PrimeScript Reverse kit (RR047A, TAKRA), and quantitative PCR (qPCR) was performed with the QuantStudio Dx real-time fluorescence quantitative PCR instrument. Relative gene expression was calculated using the 2⁻ΔΔCt method, with GAPDH serving as the internal reference. The experiment was conducted in triplicate, and the primer sequences are provided in the Table 1.Table 1Primers sequences used for qRT‑PCR.Table 1 dummy alt textGene nameForward primerReverse primerRUNX2GGACGAGGCAAGAGTTTCACGAGGCGGTCAGAGAACAAACALPGCTCCAGGGATAAAGCAGGTCGCCAGTACTTGGGGTCTTTOCNCTGACCACATCGGCTTTCAGTTATTTGGGAGCAGCTGGGABMP9AGAACGTGAAGGTGGATTTCCCGCACAATGTTGGACGCTGGAPDHACCCAGAAGACTGTGGATGGTCAGCTCAGGGATGACCTTG Table 1Primers sequences used for qRT‑PCR.Table 1 dummy alt textGene nameForward primerReverse primerRUNX2GGACGAGGCAAGAGTTTCACGAGGCGGTCAGAGAACAAACALPGCTCCAGGGATAAAGCAGGTCGCCAGTACTTGGGGTCTTTOCNCTGACCACATCGGCTTTCAGTTATTTGGGAGCAGCTGGGABMP9AGAACGTGAAGGTGGATTTCCCGCACAATGTTGGACGCTGGAPDHACCCAGAAGACTGTGGATGGTCAGCTCAGGGATGACCTTG Primers sequences used for qRT‑PCR. Western blotting Whole-cell lysates were prepared using RIPA lysis buffer (Beyotime). Protein concentration was assessed using a BCA assay kit (Beyotime). Equal amounts of protein (20 µg) were separated via SDS-PAGE (10%) and subsequently transferred onto a PVDF membrane (Merck-Millipore). Membranes were blocked using 1% bovine serum albumin (BSA) (Sigma) in Tris-buffered saline containing 0.1% Tween 20 for 1 hour, followed by overnight incubation at 4°C with primary antibodies against target proteins:Runx2 (12556S, Cell Signalling Technology, rabbit, 1:1000), OCN (AP11850PU-N, OriGene Technologies, rabbit, 1:2000), ALP (ab229126, Abcam, rabbit, 1:500), BMP9 (AP11941PU-N, OriGene Technologies, rabbit, 1:1000), Smad1/5/9 (12656, Cell Signalling Technology, rabbit, 1:1000), and p-Smad1/5/9 (13820T, Cell Signaling Technology, rabbit, 1:1000). Protein bands were visualized using enhanced chemiluminescence (ECL) solutions (Merck-Millipore). Cell transfection Small-interfering RNAs (siRNAs) targeting BMP9 (si-BMP9) and a control siRNA (si-NC) were procured from Shanghai GenePharma Co, Ltd. (Shanghai, China). hPDLFs were seeded into 6-well plates prior to transfection. Upon reaching 80% confluence, cells were transfected with siRNAs using polyethyleneimine (PEI) transfection reagent (Biowit Technologies), following the manufacturer's instructions. The sequences of the siRNAs utilized were as follows: si-BMP9 sense: CCAACAUUGUGCGGAGCUUTT antisense: AAGCUCCGCACAAUGUUGGTT si-NC sense: UUCUCCGAACGUGUCACGUTT antisense: ACGUGACACGUUCGGAGAATT ALP staining and ALP activity assay After CTS treatment, cell samples were collected, and alkaline phosphatase (ALP) activity was assessed using the Alkaline Phosphatase Activity Assay Kit (Solarbio). Post-treatment, the hPDLFs were cultured in induction medium (containing 5% FBS, 10 nM dexamethasone, 10 mM β-glycerophosphate, and 50 μg/mL ascorbic acid) for an additional 7 days. Subsequently, the culture medium was removed, and the cells were washed with phosphate-buffered saline (PBS) and fixed with a cell fixative for 15 minutes. The incubation solution was prepared in accordance with the instructions provided with the ALP staining kit (Solarbio). This solution was added and incubated for 20 minutes, after which the cells were rinsed with distilled water, observed under a microscope, and photographed. Alizarin red S (ARS) staining Following the application of CTS treatment, the hPDLFs were cultured in induction medium (containing 5% FBS, 10 nM dexamethasone, 10 mM β-glycerophosphate, and 50 μg/mL ascorbic acid) for an additional 14 days. After this period, the culture medium was discarded, and the cells were washed with PBS, fixed with 4% paraformaldehyde for 15 minutes, and washed 3 times with PBS. They were then incubated with alizarin red staining solution (Solarbio) for 30 minutes, rinsed with distilled water, observed under a microscope, and photographed. Orthodontic tooth movement model construction Male Sprague-Dawley (SD) rats, aged 11 weeks and weighing between 250 and 300 g, were procured from the Experimental Animal Centre of Jinzhou Medical University for the purpose of constructing an orthodontic tooth movement model. The maxillary incisors served as the anchorage points, while a nickel-titanium tension spring, sourced from the Research Institute in Beijing, was affixed to the first molar of the left maxilla to apply a force of 30 g in the mesial direction. The left maxillary first molar (M1) was subjected to this force for durations of 3, 7, and 14 days, respectively. The first molar of the right maxilla was designated as the control. Haematoxylin-eosin (HE) staining was employed to examine the morphological changes in the periodontal ligament (PDL) on the tension side of the proximal buccal root of M1 during the process of OTM. Micro-computed tomography (micro-CT) scans of animal specimens were employed to assess the displacement of teeth in the proximal direction of the first molar (M1). Haematoxylin-Eosin (HE) staining Periodontal ligament tissues were fixed in 4% paraformaldehyde, embedded in paraffin, sectioned (5 μm), deparaffinized, rehydrated, stained with haematoxylin for 5 min and eosin for 30 s, dehydrated, cleared, and mounted. Sections were observed under a light microscope. Immunohistochemistry For immunohistochemical (IHC) staining, tissue sections mounted on slides underwent deparaffinization, rehydration, and antigen retrieval processes. Subsequently, the slides were blocked with 10% normal goat serum for 1 hour and then incubated overnight at 4°C with primary antibodies: OCN (AP11850PU-N, OriGene Technologies, rabbit, 1:100), and BMP9 (AP11941PU-N, OriGene Technologies, rabbit, 1:100). Following 3 washes with PBST buffer, the slides were incubated with an anti-rabbit secondary antibody (Cell Signalling Technology) for one hour at room temperature and subsequently stained using a DAB kit (ZSGB-BIO). Imaging was conducted using an Olympus BX51 microscope coupled with a DP12 digital camera. Statistical analysis All data are presented as mean ± standard deviation (SD). Statistical comparisons among multiple groups were performed using one-way analysis of variance (ANOVA), while comparisons between 2 groups were conducted using the Student's t-test. A p value < .05 was considered statistically significant. Results Enhanced BMP9 expression in force-induced PDL tissues Micro-computed tomography (micro-CT) scanning were performed on the maxillary alveolar bone of rats, and specialized analytical software was employed to quantify the mesial displacement of the maxillary first molar. The results demonstrated a time-dependent increase in tooth movement distance from day 0 to day 14 (Figure 1A and B). Haematoxylin and eosin (HE) staining revealed that the periodontal ligament space on the tension side began to widen on day 3, PDL fibres loosely arranged and oriented parallelly to the direction of applied mechanical force. With prolonged force application (7 days and 14 days), the widening of the PDL space became more pronounced (Figure 1C). These observations confirmed the successful establishment of the rat OTM model in this study. OCN, an established osteogenic marker, was widely distributed throughout the PDL, and its expression increased progressively from day 0 to 14 (Figure 1 D). Furthermore, BMP9 expression was predominantly localized to the alveolar bone side of the PDL and increased gradually from day 0 to day 7, whereas a marked reduction was detected at day 14 relative to days 3 and 7 (Figure 1 E). Collectively, these findings imply that BMP9 might play a potential role in alveolar bone remodelling during OTM.Fig. 1Enhanced BMP9 expression in force-induced PDL tissues during OTM. (A) Representative micro-computed tomography of OTM at days 3, 7, and 14 after force application (F 3 d, F 7 d, F 14 d, n = 3). Arrows indicate the direction of force loading. (B) Quantitative analysis of OTM distance change (n = 3). (C) HE staining for morphological observation of periodontal ligament at 3, 7 and 14 days under mechanical force. (D-E) IHC staining and semi-quantitative analysis of OCN and BMP9 expression in PDL tissues following mechanical force stimulation for 3, 7, and 14 days. All experiments were performed in triplicate. Data are presented as mean ± SD. Statistical significance was defined as P < .05, with * indicating significant difference.Fig 1 dummy alt text Enhanced BMP9 expression in force-induced PDL tissues during OTM. (A) Representative micro-computed tomography of OTM at days 3, 7, and 14 after force application (F 3 d, F 7 d, F 14 d, n = 3). Arrows indicate the direction of force loading. (B) Quantitative analysis of OTM distance change (n = 3). (C) HE staining for morphological observation of periodontal ligament at 3, 7 and 14 days under mechanical force. (D-E) IHC staining and semi-quantitative analysis of OCN and BMP9 expression in PDL tissues following mechanical force stimulation for 3, 7, and 14 days. All experiments were performed in triplicate. Data are presented as mean ± SD. Statistical significance was defined as P < .05, with * indicating significant difference. Isolation and identification of primary hPDLFs Primary cell cultures were isolated using the explant method, and this procedure took 7-10 days. During this process, cells were observed to migrate radially from the periphery of tissue explants, displaying a typical spindle-shaped morphology. Subsequent subculture was performed via the differential adhesion technique, allowing the cells to reach 70% to 80% confluence within 3 to 5 days (Figure 2A). Immunofluorescence staining showed that the cells were positive for vimentin and fibroblast-specific protein 1 (FSP1), while negative for cytokeratin10. These finding indicated that cells were derived from mesenchymal tissue and devoid of epithelial contamination (Figure 2B). Growth curve analysis of passage 4 cells showed a typical sigmoidal pattern, which was characterized by distinct lag, exponential, and plateau phases (Figure 2C). In summary, primary hPDLFs were successfully isolated and cultured, and the identified cell characteristics guaranteed their reliability for subsequent experiments.Fig. 2Primary culture and identification of hPDLFs. (A) Cells began to migrate out from adherent tissue blocks after approximately 1 week of in vitro culture. After 2 weeks of culture, isolated single cells exhibited stable adhesion and proliferation following trypsin digestion. (B) The Vimentin, CK10, and FSP1 protein expression of hPDLFs was detected by immunofluorescence assay. (C) Cell proliferation curve of hPDLFs. All cellular experiments were repeated in triplicate. Data are presented as mean ± SD. Statistical significance was defined as *P < .05.Fig 2 dummy alt text Primary culture and identification of hPDLFs. (A) Cells began to migrate out from adherent tissue blocks after approximately 1 week of in vitro culture. After 2 weeks of culture, isolated single cells exhibited stable adhesion and proliferation following trypsin digestion. (B) The Vimentin, CK10, and FSP1 protein expression of hPDLFs was detected by immunofluorescence assay. (C) Cell proliferation curve of hPDLFs. All cellular experiments were repeated in triplicate. Data are presented as mean ± SD. Statistical significance was defined as *P < .05. CTS induction of the osteogenic differentiation in hPDFLs ALP is widely acknowledged as an early marker of osteogenic differentiation. A colorimetric assay was performed to measure ALP activity. The results revealed that ALP activity increased progressively upon CTS exposure and peaked at 12 hours. Specifically, ALP activity in the 6-hour, 12-hour, and 24-hour CTS-treated groups was significantly elevated compared to the 0-hour control group (p < .05) (Figure 3A). qRT‑PCR analysis indicated that the expression levels of Runx2, ALP, and OCN at mRNA level were upregulated following CTS application. Runx2 and ALP mRNA levels peaked at 12 hours, whereas OCN expression reached its maximum at 6 hours. Compared with the 0‑hour control group, the 6‑hour, 12‑hour, and 24‑hour groups exhibited significantly higher expression of Runx2, ALP, and OCN (p < .05) (Figure 3 B-D). The protein expression levels of Runx2, ALP, and OCN showed a time-dependent upward trend. (Figure 3E-H). After 7 days of osteogenic induction, hPDLFs with 6, 12, and 24 hours CTS exposure exhibited gradually increased ALP activity compared with the untreated 0‑hour control group. (Figure 3I). After 14 days of osteogenic induction, ARS staining revealed numerous clustered red mineralized nodules in the CTS-treated groups as compared with the untreated 0‑hour control group (Figure 3J). Collectively, these results demonstrate that CTS effectively induces the osteogenic differentiation potential of hPDLFs.Fig. 3CTS promotes the osteogenic differentiation of hPDLFs. (A) Quantiative ALP activity assay was performed to explore the effect of CTS treatment for 0, 6, 12 and 24h on ALP activity in hPDLFs. (B-D) The mRNA expression levels of Runx2, OCN and ALP were measured via qRT-PCR after CTS stimulation at the above time points, with GAPDH serving as the internal reference. (E-H) Western blot analysis was used to detect the protein expression of Runx2, OCN and ALP following CTS treatment, the expression levels were normalized to β-actin. (I) ALP staining was conducted to assess the ALP activity in hPDLFs exposed to CTS for 0, 6, 12 and 24 hours. (J) Alizarin Red S staining was applied to observe mineralized nodules formation in hPDLFs after corresponding CTS intervention. All cell experiments were repeated 3 times. Data are presented as mean ± SD. *P < .05 vs. the control group.Fig 3 dummy alt text CTS promotes the osteogenic differentiation of hPDLFs. (A) Quantiative ALP activity assay was performed to explore the effect of CTS treatment for 0, 6, 12 and 24h on ALP activity in hPDLFs. (B-D) The mRNA expression levels of Runx2, OCN and ALP were measured via qRT-PCR after CTS stimulation at the above time points, with GAPDH serving as the internal reference. (E-H) Western blot analysis was used to detect the protein expression of Runx2, OCN and ALP following CTS treatment, the expression levels were normalized to β-actin. (I) ALP staining was conducted to assess the ALP activity in hPDLFs exposed to CTS for 0, 6, 12 and 24 hours. (J) Alizarin Red S staining was applied to observe mineralized nodules formation in hPDLFs after corresponding CTS intervention. All cell experiments were repeated 3 times. Data are presented as mean ± SD. *P < .05 vs. the control group. CTS upregulates the BMP9/Smad1/5/9 signalling pathway in hPDLFs Since BMP9 is crucial for osteogenic differentiation, hPDLFs were treated with CTS at different time points (0, 6, 12, and 24 h), followed by detection of BMP9 expression. qRT‑PCR analysis revealed that BMP9 mRNA expression increased in a time-dependent upon CTS exposure and maximized at 12 hours (Figure 4A). Western blot analysis further confirmed a time-dependent upregulation of BMP9 protein (Figure 4B and C). Furthermore, CTS markedly upregulated the expression of phosphorylated Smad1/5/9 (p-Smad1/5/9) in a time-dependent manner, whereas the total Smad1/5/9 protein levels remained unchanged (Figure 4D and E). These findings indicate that CTS treatment increases the expression of BMP9 and p-Smad1/5/9 in hPDLFs, suggesting that the BMP9/p-Smad1/5/9 signalling pathway may be involved in CTS-induced osteogenic differentiation.Fig. 4CTS upregulates the BMP9/Smad1/5/9 signaling pathway in hPDLFs. (A) qRT-PCR analysis of relative BMP9 mRNA expression in hPDLFs subjected to CTS stimulation for 0, 6, 12 and 24h. the expression levels were normalized to GAPDH. (B-C) Western blot analysis the BMP9 protein expression after CTS treatment for 0, 6, 12 and 24 hours, the expression levels were normalized to β-actin. (D-E) Western blot analysis the Smad1/5/9 and p-Smad1/5/9 protein expression following CTS intervention at the indicated time points, the expression levels were normalized to β-actin. All cellular experiments were repeated 3 times. Data are presented as mean ± SD. *P < .05 vs. the control group.Fig 4 dummy alt text CTS upregulates the BMP9/Smad1/5/9 signaling pathway in hPDLFs. (A) qRT-PCR analysis of relative BMP9 mRNA expression in hPDLFs subjected to CTS stimulation for 0, 6, 12 and 24h. the expression levels were normalized to GAPDH. (B-C) Western blot analysis the BMP9 protein expression after CTS treatment for 0, 6, 12 and 24 hours, the expression levels were normalized to β-actin. (D-E) Western blot analysis the Smad1/5/9 and p-Smad1/5/9 protein expression following CTS intervention at the indicated time points, the expression levels were normalized to β-actin. All cellular experiments were repeated 3 times. Data are presented as mean ± SD. *P < .05 vs. the control group. BMP9/Smad1/5/9 promotes osteogenic differentiation in CTS-induced hPDLFs The regulatory effect of BMP9 on the osteogenic differentiation of hPDLFs was further confirmed using siRNA against BMP9 (si-BMP9) (Figure 5A and B). hPDLFs transfected with either si-NC or si-BMP9 were exposed to CTS at a magnitude of 10% for 24 hours. hPDLFs with si-BMP9 downregulated the protein expression of Runx2, OCN, and ALP (Figure 5E, G). The osteogenic differentiation capacity was also assessed by ALP staining after 7 days of osteogenic differentiation and by ARS staining after 14-day culture. The results revealed that, compared with the si-NC group, the si-BMP9 group exhibited a significant reduction in intracellular blue-stained granules and flaky precipitates, accompanied by significantly smaller red granular mineralized nodules (Figure 5C and D). Our results also revealed decreased phosphorylation level of Smad1/5/9 in si-BMP9 group in relative to si-NC groups upon CTS treatment (Figure 5F-G). Moreover, Immunofluorescent staining using anti-Smad1/5/9 showed decreased fluorescence intensity in the nucleus of the si-BMP9 cells (Figure 5H).Fig. 5Silencing BMP9 attenuated CTS-induced osteogenic differentiation in hPDLFs. (A-B) Western blot analysis of BMP9 protein expression in hPDLFs transfected with siRNA-NC or siRNA-BMP9, β-actin was used as the internal reference. (C) ALP staining was performed to detect ALP activity in hPDLFs with siRNA-NC or siRNA-BMP9 transfection following CTS stimulation. (D) Alizarin Red S staining was used to observe the formation of mineralized nodules in hPDLFs upon siRNA-NC/siRNA-BMP9 transfection after CTS treatment. (E-G) Western blot quantification of Runx2, ALP, OCN, Smad1/5/9 and p-Smad1/5/9 protein levels in hPDLFs transfected with siRNA-NC or siRNA-BMP9 under CTS intervention, the expression levels were normalized to β-actin. (H) Immunofluorescence staining was applied to evaluate expression and subcellular localization of p-Smad1/5/9 in CTS-treated hPDLFs after BMP9 knockdown. All cellular experiments were conducted 3 times. Data are presented as mean ± SD. P < .05 was marked as *.Fig 5 dummy alt text Silencing BMP9 attenuated CTS-induced osteogenic differentiation in hPDLFs. (A-B) Western blot analysis of BMP9 protein expression in hPDLFs transfected with siRNA-NC or siRNA-BMP9, β-actin was used as the internal reference. (C) ALP staining was performed to detect ALP activity in hPDLFs with siRNA-NC or siRNA-BMP9 transfection following CTS stimulation. (D) Alizarin Red S staining was used to observe the formation of mineralized nodules in hPDLFs upon siRNA-NC/siRNA-BMP9 transfection after CTS treatment. (E-G) Western blot quantification of Runx2, ALP, OCN, Smad1/5/9 and p-Smad1/5/9 protein levels in hPDLFs transfected with siRNA-NC or siRNA-BMP9 under CTS intervention, the expression levels were normalized to β-actin. (H) Immunofluorescence staining was applied to evaluate expression and subcellular localization of p-Smad1/5/9 in CTS-treated hPDLFs after BMP9 knockdown. All cellular experiments were conducted 3 times. Data are presented as mean ± SD. P < .05 was marked as *. To further demonstrate the role of BMP9/Smad1/5/9 signalling in CTS induced osteogenic differentiation, hPDLFs were pretreated with LDN193189, a specific inhibitor of Smad1/5/9, and followed by CTS exposure for 24 hours. As shown in Figure 6A and B, Smad1/5/9 phosphorylation level was obviously reduced in the CTS+LDN group compared with the CTS+DMSO group, whereas total Smad1/5/9 protein levels remained unaltered. Further analysis showed that pretreatment with LDN markedly decreased the protein expression of Runx2, ALP, and OCN compared with the untreated control (p < .05) (Figure 6C and D). Simultaneously, a marked reduction in ALP staining and less mineralized nodules were observed in the CTS+LDN group than CTS+DMSO group (Figure 6E and F). Collectively, these findings suggest that the BMP9/Smad1/5/9 signalling axis serves as a critical mediator of CTS-induced osteogenic differentiation in hPDLFs.Fig. 6Inhibition of the BMP9/Smad1/5/9 signaling pathway decreased osteogenic differentiation of hPDLFs induced by CTS. (A-B) Western blot analysis of Smad1/5/9 and p-Smad1/5/9 protein expression in hPDLFs. Cells were pretreated with LDN193189 for 24 h prior to CTS exposure, protein expression levels were normalized to β-actin. (C-D) Western blot analysis of Runx2, OCN and ALP protein expression in hPDLFs. Cells were pretreated with LDN193189 for 24 h before CTS treatment, protein expression levels were normalized to β-actin. (E) ALP staining was performed to evaluate ALP activity in hPDLFs pretreated with LDN193189 for 24 h following CTS stimulation. (F) Alizarin Red S staining was used to observe mineralized nodules formation in hPDLFs after 24 hours LDN193189 pretreatment and subsequent CTS intervention. All cellular experiments were repeated 3 times. Data are presented as mean ± SD. P < .05 was marked as *.Fig 6 dummy alt text Inhibition of the BMP9/Smad1/5/9 signaling pathway decreased osteogenic differentiation of hPDLFs induced by CTS. (A-B) Western blot analysis of Smad1/5/9 and p-Smad1/5/9 protein expression in hPDLFs. Cells were pretreated with LDN193189 for 24 h prior to CTS exposure, protein expression levels were normalized to β-actin. (C-D) Western blot analysis of Runx2, OCN and ALP protein expression in hPDLFs. Cells were pretreated with LDN193189 for 24 h before CTS treatment, protein expression levels were normalized to β-actin. (E) ALP staining was performed to evaluate ALP activity in hPDLFs pretreated with LDN193189 for 24 h following CTS stimulation. (F) Alizarin Red S staining was used to observe mineralized nodules formation in hPDLFs after 24 hours LDN193189 pretreatment and subsequent CTS intervention. All cellular experiments were repeated 3 times. Data are presented as mean ± SD. P < .05 was marked as *. Discussion hPDLFs, the principal cellular component of the periodontal ligament and significantly more numerous than hPDLSCs, exhibit stem cell-like properties.30 hPDLSCs are capable of differentiating into hPDLFs, and reciprocally, hPDLFs can also induce the differentiation of hPDLSCs.31 As mechanosensitive cells, hPDLFs exhibit osteogenic potential under mechanical stimulation. Research has demonstrated that orthodontic force modulates the osteogenic differentiation of hPDLFs via the ZBTB16/Wnt/β-catenin signalling pathway.32 Ren et al. have revealed that periodic tensile stress stimulates PDLFs and enhances the gene expression of SP7, OCN, and BSP, thereby promoting osteogenic differentiation.33 During the course of orthodontic tooth movement, fibroblasts within the PDL are the primary cells to receive mechanical strain stimuli. Therefore, the osteogenic differentiation capacity of hPDLFs determines the remodelling rate of periodontal bone tissue. In the present study, we observed that CTS increased the protein expression of Runx2, OCN, and ALP in hPDLFs, thereby facilitating osteogenic differentiation. Orthodontic force causes the tooth to deviate from its original position, leading to the stretching and tightening of the periodontal ligament fibres on one side. The primary cells within the periodontal ligament—fibroblasts and osteoblasts—perceive this mechanical tension. This biomechanical stimulation activates intracellular signalling pathways, such as the MAPK and Wnt/β-catenin pathways.34, 35, 36 The activated cells begin to release a series of cytokines and growth factors, including prostaglandins, transforming growth factor-beta (TGF-β), BMPs, insulin-like growth factor (IGF), among others.37 The activated fibroblasts and osteoblasts initiate the synthesis and extensive secretion of type I collagen fibres, forming a collagen-rich osteoid matrix on the tension side, which serves as a "scaffold" for new bone formation. Our in vivo findings confirmed that BMP9 expression was elevated on the alveolar bone surface of the tension side during orthodontic tooth movement. In a rat model of calvarial bone defect, BMSCs overexpressing BMP9 can significantly alleviate pathological injury and increase collagen fibre production, thereby effectively repairing damaged bone tissue in rats with calvarial defects.38 Another study on tooth development also demonstrated that BMP9‑knockout mice exhibited shorter alveolar bone, decreased bone mineral density, trabecular thickness, and bone volume fraction.39 Accumulating evidence indicates that CTS exerts a promoting effect on the osteogenic differentiation of periodontal ligament cells by upregulating BMP9 expression.29 Based on these data, we hypothesize that BMP9 plays important roles in alveolar bone remodelling during OTM. To validate our hypothesis, we employed the tissue explant technique to culture primary hPDLFs and employed RNA interference to knock down BMP9 expression in these cells. Empirical evidence has shown that the osteogenic differentiation potential of hPDLFs is impaired when BMP9 expression is suppressed. Recombinant human BMP9 protein promotes the osteogenic differentiation of PDLFs by activating the ERK, p38 kinase, and NF-κB signalling pathways.40,41 Thus, we speculate that BMP9 may play a potential role in alveolar bone remodelling during OTM. However, the mechanism by which BMP9 functions in hPDLFs under CTS remains largely unexplored. Osteogenic differentiation is a multifaceted physiological process primarily mediated by BMP9 and involves multiple signalling pathways, including BMP9/Smad, MAPK, PI3K, Wnt/β-catenin, Hedgehog, EGF, TGF-β, and Notch.42,43 Nowdays, the BMP9-Smad pathway is recognized as one of the most potent regulators of osteogenic differentiation. The process can be delineated as follows: BMP9 homodimers and BMP9/BMP10 heterodimers interact with BMP type II receptors, which subsequently phosphorylate BMP type I receptors, leading to the phosphorylation of SMAD1/5/8. This phosphorylation facilitates the binding of SMAD1/5/8 to SMAD4, promoting its translocation from the cytoplasm to the nucleus, where the Smad1/5/8-Smad4 complex regulates the expression of osteogenesis-related genes such as Runx2, Dlx5, and OSX.44 Previous research has suggested that BMP9 facilitates the osteogenic differentiation of PDLFs through the activation of the JNK/Smad2/3 signaling pathway.45 Additionally, a study by Weiran Li identified the YY1/SNHG5/miR-212-3p/GDF5/Smad pathway as a mediator of osteogenic differentiation in human bone marrow-derived mesenchymal stem cells, highlighting its potential as a therapeutic target for addressing bone loss.46 In vitro experiments revealed that the expression levels of BMP9 and p-Smad1/5/9 in hPDLFs were gradually upregulated in a time-dependent manner. Furthermore, CTS promoted the nuclear translocation of p-Smad1/5/9, whereas BMP9 inhibition reversed this nuclear translocation of p-Smad1/5/9. Based on these observations, we hypothesize that the BMP9/Smad1/5/9 signalling pathway is activated under CTS, thereby facilitating the osteogenic differentiation of hPDLFs. To rigorously test this hypothesis, we employed siRNA interference techniques to generate BMP9 knockdown cell lines. Additionally, we used the kinase inhibitor LDN193189 to inhibit Smad1/5/9 kinase activity. The BMP9-Smad1/5/9 axis is implicated in transmitting osteogenic signals that drive the osteogenic differentiation process. Our findings indicate that the downregulation of BMP9 expression leads to decreased levels of phosphorylated Smad1/5/9. Moreover, treatment with a Smad1/5/9 kinase inhibitor attenuated the CTS-induced osteogenic differentiation of hPDLFs. Collectively, these results support our hypothesis. However, the regulatory role of the BMP9/Smad1/5/9 signalling pathway remains to be further validated in vivo. In addition, only a single inhibitor was applied in this study. These shortcomings constitute the major limitations of the current work, and we will perform more in-depth investigations in our follow-up research. Conclusions Our study demonstrates that cyclic tensile stress upregulates BMP9 expression in hPDLFs, which subsequently activates Smad1/5/9 signalling and promotes the nuclear expression of transcription factors associated with osteogenic differentiation. These results suggest that BMP9 may serve a critical role in alveolar bone remodelling. Collectively, these findings elucidate additional mechanisms underlying osteogenic differentiation of hPDLFs and provide a theoretical framework for accelerating orthodontic tooth movement. Ethical approval This study was approved by the Ethics Committee of the First Affiliated Hospital (#JZMULL2025379) and the Ethics Committee of the Animal Center (#2023055) of Jinzhou Medical University. Informed consent has been obtained from patients for the publication of all data for the study. Author contributions Jing Hu: Conceptualization, Writing and Editing, Funding acquisition and experimental operation. Ni An and Song Zhao: Acquisition of data and experimental operation. Sheng Chang: Writing the manuscript. Rongjian Su; Writing and revision of the manuscript. Jin Huang: Funding acquisition and Writing the manuscript. Conflict of interest None disclosed.